Open access
Open access
Powered by Google Translator Translator

Patient Preference RCT | Short-term anti-TNF therapy with surgical closure vs. anti-TNF therapy alone in the treatment of perianal fistulas in Crohn’s disease.

21 Sep, 2022 | 13:09h | UTC

Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn’s disease (PISA-II): a patient preference randomised trial – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)

Podcast: Elise Meima-van Praag on surgical closure for Crohn’s disease perianal fistulas

Commentary: Anti-TNF, surgical closure induces long-term healing in Crohn’s fistulas – Healio (free registration required)

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.